FORZA™ is now in a phase 2 clinical trial in Progressive Multiple Sclerosis in partnership with the Italian National Multiple Sclerosis Association and Foundation, the General Hospital of San Martino, in Genoa, Italy, and the Sant'Andrea Medical and Psychology Hospital at La Sapienza University in Rome, Italy:
Exploratory Trial of Forza™️, a Novel Nutraceutical From Actinidia Deliciosa Plants Bioengineered to Bio-encapsulate the Osmotin Plant Protein as Adjuvant for the Treatment of Progressive Multiple Sclerosis
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Copyright © 2022
9th Dimension Biotech, Inc.
All Rights Reserved.
By accepting, you agree that your data will be aggregated with the data of all other users.